Real-World Data / Real-Word Evidence Resources

  1. The EMR Interoperability Dream Vs. Clinical Research Reality 10/20/2025

    Seamless Electronic Medical Record access promises accelerated trials and regulatory-grade evidence, but incomplete, unstructured data requires hybrid strategies using AI and human oversight to bridge gaps.

  2. Choosing An EDC With A Robust API For DTx Clinical Trials 4/20/2022

    This white paper explores the importance of choosing an EDC with an API before starting a clinical trial.

  3. The Future Of Health Data: A 2022 Life Sciences Industry Insights Report 11/14/2022

    A survey of life sciences leaders reveals some of the key challenges that come with using real-world data (RWD) for innovation, along with their vision and predictions for how RWD can accelerate drug development and improve patient outcomes.

  4. A Few Clicks And Done: Automating EDC Data Entry 4/7/2024

    A novel solution has emerged to tackle the inefficiency and errors in manual data re-entry during clinical trials, streamlining data entry, eliminate application switching, and benefit all stakeholders.

  5. Why Research Sites Don't Use EMR As The Source Data Collection Tool 9/21/2022

    Examine the limitations of using Electronic Medical Records (EMRs) in clinical research compared to eSource systems.

  6. RWD For Early Clinical Development Planning And Strategy 9/19/2023

    Delve into this use case where Citeline’s Real-World Data was used to inform clinical development strategy and differentiate target product profiles through patient journey mapping.

  7. Unlocking The Power Of Real-World Evidence In FDA Submissions 5/15/2023

    Understand the gaps between how data is collected in real-world evidence (RWE) and randomized clinical trials (RCT) and how RWE is quickly finding ways to catch up.

  8. The Pharmaceutical Industry: 2024 (And Beyond) Predictions 1/24/2024

    DCTs, RWD, IRA … our industry predictions for 2024 are filled with acronyms. As we delve into 2024, explore what trends are hot ― and not ― for the coming year, and their impact on the industry.

  9. RWD/RWE In 2023: Regulatory Policy World Tour 7/5/2023

    Learn about what the industry considers RWD/RWE priorities for the year, as well as current efforts being taken within each region around the globe.

  10. Expedite Drug Development With An Integrated CDMO-CRO Model 2/6/2026

    From optimizing first-in-human strategies to leveraging AI-enabled digital architectures, the integrated CDMO-CRO services model reduces risk and maximizes program value.